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Objectives: A major concern in the long-term success
of EVAR is stent-graft migration, which can cause type I
endoleak and even aneurysm rupture. Fixation depends on
mechanical forces between the graft and the aortic neck.
Therefore there are anatomical restrictions for EVAR, such
as short and angulated necks. To improve the fixation of
EVAR-grafts, elastomer (PDMS) can be injected in the
aneurysm sac. The support given by the elastomer might
prevent dislocation and migration of the graft. The aim of
this study was to measure the influence of an injectable
biocompatible elastomer on the fixation strength of differ-
ent EVAR-grafts in an in-vitro model.
Methods: The proximal part of 3 different stent grafts
(Gore Excluder®, Vascutek Anaconda® and Medtronic
Endurant®) was inserted in a bovine artery with an attached
latex aneurysm. The graft was connected to a tensile testing
machine, applying force to the proximal fixation, while the
artery with the aneurysm was fixated to the set-up. The force
to obtain graft dislodgement (DF) from the aorta was re-
corded in Newtons (N). Three different proximal seal lengths
(5, 10 and 15 mm) were evaluated. The experiments were
repeated after the space between the graft and the latex aneu-
rysm was filled with the elastomer. Independent sample T-
testswere used for the comparisonbetween theDFbefore and
after elastomer treatment for each seal length.
Results: The mean DF (mean  SD) of all grafts
without elastomer sac filling for a proximal seal length of 5,
10 and 15 mm were respectively, 4.4  3.1N, 12.2 
10.6N and 15.1  6.9N. After elastomer sac-filling the
dislodgement forces increased significantly (p 0.001) to:
20.9  3.8N, 31.8  9.8N and 36.0  14.1N.
Conclusions: The present study shows that aneurysm
sac filling may have a role as an adjuvant procedure to the
present EVAR technique. The strength of the proximal
fixation of 3 different stent-grafts increases significantly in
this in-vitro setting.
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Objectives: To evaluate mid-term clinical outcomes
after use of a new commercially available device for endo-
vascular repair of abdominal aortic aneurysm (EVAR).
Methods: Patient’s demographics, aneurysm mor-
phology, perioperative and follow-up outcome variables
of all patients treated with Anaconda bifurcated stent-
graft between 2005 and 2009 were prospectively col-
lected into a dedicated database. Patients were followed
up at 1, 6 and 12 months and yearly thereafter with spiral
computed tomography angiography. Aortic neck and
aneurysm sac evolution were analyzed by comparing
mean diameters at different follow-up intervals. Kaplan-
Meier analysis was performed to evaluate midterm clini-
cal success of the treatment.
Results: A total of 97 consecutive patients (85 male,
mean age 77.5  6.6 years) were treated during the study
period. Mean follow-up duration was 36.4  9.3 months
(range 1-51). There were 12 type II endoleak (18.4%), 5
reintervention (7.7%) and one case of aneurysm related
mortality (1.5%). No type I or III endoleak and no migra-
tion or conversion were observed. Aortic neck remained
substantially stable during the follow-up (mean aortic
neck diameter 26.4  4.1 mm at 1 month, 26.8  3.8
mm at 36-months; p  0.6). There was a significant sac
shrinkage (mean AAA diameter 53.7  7.2 mm preop-
eratively, 35.4  15.3 mm at 36-months; p  0.02).
Kaplan-Meier estimates showed a 36 months freedom
from endoleak, reintervention and sac enlargement of
63.9%, 87.3% and 89.3%, respectively, with a cumulative
survival of 83.7%.
Conclusions: EVAR with Anaconda stent-graft repre-
sents a safe and effective alternative to open surgery in
patients with suitable AAA. Midterm results show signifi-
cant aneurysm sac shrinkage in absence of proximal aortic
neck modifications.
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